A study published in Nature Communications unveils a new platform for discovering cellular signatures of disease that integrates robotic systems for [.]
Combining AI and robotics technology, researchers have identified new cellular characteristics of Parkinson's disease in skin cell samples from patients.
A study, appearing in the journal Nature Communications, reveals a new system for finding cellular signatures of disease that incorporates robotic platforms for analyzing patient cells with artificial intelligence (AI) approaches for image analysis.
NYSCF researchers hope that the platform will point to new therapeutic avenues for many diseases where traditional drug discovery has been unsuccessful.